TP53BP2 and metabolic dysfunction-associated steatotic liver disease: These findings suggest that ASPP2 can promote adaptive immune maturation through alterations in the gut microbiota, which may be an important mechanism by which ASPP2 deficiency leads to disorders of fatty acid metabolism and the onset of NAFLD.